VirA+EmiC project: Evaluating real‐world effectiveness and sustainability of integrated routine opportunistic hepatitis B and C testing in a large urban emergency department

Author:

Nebbia Gaia1ORCID,Ruf Murad2,Hunter Laura3,Balasegaram Sooria4,Wong Terry5,Kulasegaram Ranjababu6,Surey Julian78,Khan Zana9,Williams Jack10ORCID,Karo Basel11,Snell Luke1,Flower Barnaby12,Evans Hannah413,Douthwaite Sam1

Affiliation:

1. Department of Infection Guy's and St Thomas' NHS Foundation Trust London UK

2. Gilead Sciences Ltd UK & Ireland Medical Department London UK

3. Department of Emergency Medicine Guy's and St Thomas' NHS Foundation Trust London UK

4. Field Epidemiology Service National Infection Service UK Health Security Agency, London UK London UK

5. Gastroenterology and Hepatology Department Guy's and St Thomas' NHS Foundation Trust London UK

6. Department of HIV/GU Medicine Guy's and St Thomas' NHS Foundation Trust London UK

7. Institute for Global Health University College London London UK

8. Universidad Autónoma de Madrid Madrid Spain

9. Institute of Epidemiology and Health Care UCL and South London and Maudsley Trust London UK

10. Department of Health Services Research and Policy London School of Hygiene and Tropical Medicine London UK

11. International Health Protection (ZIG 1) Robert Koch Institute (RKI) Berlin Germany

12. Division of Infectious Diseases Imperial College London London UK

13. UK Field Epidemiology Training Programme UK Health Security Agency London UK

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Reference33 articles.

1. Public Health England.Hepatitis C in the UK 2020: Working to eliminate hepatitis C as a major public health threat. 2020.https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/943154/HCV_in_the_UK_2020.pdfAccessed 30 July 2021

2. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

3. National Institute for Health and Care Excellence.Sofosbuvir–velpatasvir for treating chronic hepatitis C. Technology appraisal guidance [TA430].2017.https://www.nice.org.uk/guidance/ta430Accessed 30 July 2021

4. National Institute for Health and Care Excellence.Hepatitis B (chronic): diagnosis and management. Clinical guideline [CG165].2017.https://www.nice.org.uk/guidance/cg165Accessed 30 July 2021

5. World Health Organization.Global health sector strategy on viral hepatitis 2016–2021.2016.https://apps.who.int/iris/handle/10665/246177Accessed 30 July 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3